You are here:

levonorgestrel (Kyleena)


Following a full submission:

levonorgestrel (Kyleena®) is accepted for use within NHS Scotland.

Indication under review: contraception for up to 5 years.

A phase III, open-label, randomised study confirmed the contraceptive efficacy of levonorgestrel 19.5mg intrauterine delivery system according to the Pearl Index.

Drug Details

Drug Name: levonorgestrel (Kyleena)
SMC Drug ID: 1299/18
Manufacturer: Bayer Plc
Indication: Contraception for up to 5 years.
BNF Category:
Submission Type: Full submission
Status: Accepted
Date Advice Published: 12 February 2018